Loading clinical trials...

Efficacy and Safety of Oral Febuxostat in Participants With Gout | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT00430248

Efficacy and Safety of Oral Febuxostat in Participants With Gout

The purpose of this study is to compare the efficacy and safety of febuxostat, once Daily (QD), to allopurinol in subjects with hyperuricemia and gout.

Lead sponsor: Takeda•258 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 3

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

NCT07089888 · Tophaceous Gout

RECRUITINGPhase 2

A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis

NCT07453004 · Acute Gouty Arthritis

RECRUITING

The Orienting Study

NCT07504146 · CPPD - Calcium Pyrophosphate Deposition Disease, Gout

RECRUITINGPhase 3

A Study of Dotinurad Versus Allopurinol in Participants With Gout

NCT07089875 · Gout

RECRUITINGPhase 2

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

NCT07116746 · Gout, Gouty Arthritis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 2, 2012Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment2,269

Start dateFeb 2007

Last updatedFeb 2, 2012

Condition

Gout

Locations shown

Birmingham, Alabama

Hoover, Alabama

Hueytown, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2012Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions